Role of health technology assessment in pharmaceutical market access in developed countries

Kahveci, Rabia and Oortwijn, Wija and Godman, Brian and Meltem Koç, E. and Tibet, Birol; Wertheimer, Albert I. and Kockaya, Guvenc, eds. (2018) Role of health technology assessment in pharmaceutical market access in developed countries. In: Pharmaceutical Market Access in Developed Markets. SEEd Medical Publishers, Italy, pp. 225-256. ISBN 8897419739

[thumbnail of Kahveci-etal-SEEd-2017-Role-of-health-technology-assessment-in-pharmaceutical]
Preview
 Text (Kahveci-etal-SEEd-2017-Role-of-health-technology-assessment-in-pharmaceutical)
Kahveci_etal_SEEd_2017_Role_of_health_technology_assessment_in_pharmaceutical.pdf
Final Published Version
Download (780kB)| Preview

    Abstract

    Introduction and use of a health technology in a health care setting has clinical, economic, as well as organizational, social-cultural, legal and ethical impacts. Health Technology Assessment (HTA) is a multidisciplinary field that addresses these impacts, considering healthcare context as well as available alternatives. HTA mainly aims to inform policy and clinical decision making. While systematically evaluating the effects of the health technology, HTA addresses direct and intended effects as well as the indirect and unintended effects. It is a multidisciplinary field with well-developed systematic processes and methods

    CORE (COnnecting REpositories)